期刊文献+

淋病奈瑟球菌表面Porin B蛋白特异性及免疫保护性临床应用价值分析 被引量:1

Analysis of the clinical application value of the specificity and immunoprotection of Porin B protein on the surface of Neisseria gonorrhoeae
暂未订购
导出
摘要 目的研究淋病奈瑟球菌(NG)表面Porin B(Por B)蛋白特异性及免疫保护性在临床中的应用价值。方法登录Gen Bank获取NG世界卫生组织(WHO)标准株E株Por B-PIA基因,设计引物与合成,培养WHO标准株E株,通过聚合酶链反应(PCR)扩增出Por B-PIA DNA片段,采用GST·Bind^(TM)树脂纯化Por B蛋白,对噬菌体随机12肽库进行筛选并对阳性克隆进行提取,应用DNA测序及MIXOX软件分析;将培养后的人尿道上皮细胞分别与Por B蛋白特异性结合的多肽、NG活菌进行培养,并将未加入抗体作为对照组。观察Por B蛋白的纯化表达,Western blot检测Por B蛋白与NG特异性关系,间接酶联免疫吸附试验(ELISA)检测筛选后蛋白的特异性抗体水平,比较Por B蛋白特异性结合多肽对细胞内形成微菌落的差异。结果Ecoli-BL21中克隆表达的诱导产物经Ni+-NTA Purification System纯化后,获得纯度较高的Por B蛋白;制备出Por B蛋白相应的特异性结合多肽,蛋白出现特异性条带;间接ELISA检测筛选后蛋白的特异性抗体水平,筛选后蛋白的抗体水平在1∶200;加入Por B蛋白特异性结合多肽的组形成的微菌落显著少于对照组(P<0.05)。结论NG表面Por B蛋白发挥显著特异性和免疫保护性,但还需大量研究及临床试验来证明其临床效果并进一步分析Por B蛋白的相关机制和作用,为临床NG疫苗的研究提供依据。 Objective To study the clinical application value of the specificity and immunoprotection of Porin B(Por B)protein on the surface of Neisseria gonorrhoeae(NG).Methods The Por B-PIA gene of the world health organization(WHO)standard strain E of NG was obtained from Gen Bank,primers were designed and synthesized,and the standard strain E of the WHO strain was cultured.The Por B-PIA DNA fragment was amplified by PCR,and the Por B protein was purified by GST·Bind^(TM) resin.The phage random 12 peptide library was screened and positive clones were extracted,DNA sequencing and MIXOX software analysis were used;the cultured human urethral epithelial cells were cultured with peptides specifically binding to Por B protein and NG live bacteria,and no antibody was added as a control group.The purified expression of Por B protein was observed.The specific relationship between Por B protein and NG was identified by Western blot.Indirect enzyme-linked immunosorbent assay(ELISA)was used to detect and screen the specific antibody level of the protein.The difference of Por B protein specific binding polypeptide on the formation of microcolonies in cells was compared.Results After the induced product cloned and expressed in Ecoli-BL21 was purified by the Ni+-NTA Purification System,the Por B protein with higher purity is obtained.The specific binding peptide corresponding to the Por B protein was prepared,and the protein has a specific band.After the specific antibody level of the protein is screened by indirect ELISA,the antibody level was 1∶200.The microcolonies formed by the Por B protein-specific binding polypeptide group were significantly lower than those of the control group(P<0.05).Conclusions The Por B protein on the surface of NG exerts remarkable specificity and immunoprotection,but a large number of studies and clinical trials are needed to prove its clinical effect and further analyze the related mechanism and role of Por B protein,so as to provide a basis for clinical NG vaccine research.
作者 吴学良 戴礼记 王威 李兴 张妮 易军 曾志平 刘拥荣 WU Xueliang;DAI Liji;WANG Wei;LI Xing;ZHANG Ni;YI Jun;ZENG Zhiping;LIU Yongrong(Andrology Center,Ningxiang Hospital Affiliated to Hunan University of Traditional Chinese Medicine,Ningxiang 410600,Hunan,China;Department of Pharmacy,Ningxiang Hospital Affiliated to Hunan University of Traditional Chinese Medicine,Ningxiang 410600,Hunan,China;Medical Laboratory Center,Ningxiang Hospital Affiliated to Hunan University of Traditional Chinese Medicine,Ningxiang 410600,Hunan,China)
出处 《中国性科学》 2022年第8期136-140,共5页 Chinese Journal of Human Sexuality
基金 湖南省卫生计生委科研计划课题(B2016223) 宁乡市人民医院校院联合科研基金项目(2019LLXY10)。
关键词 淋病奈瑟球菌 Porin B蛋白 特异性 免疫性 Neisseria gonorrhoeae Porin B protein Specificity Immunity
  • 相关文献

参考文献9

二级参考文献54

  • 1Gulati S, Zheng B, Reed GW, et al. Immunization against a sac charide epitope accelerates clearance of experimental gonococcal infection[J]. PLoS Pathog, 2013, 9(8): e1003559.
  • 2Li G, Jiao H, Jiang G, et al. Neisseria gonorrhoeae NspA in- duces specific bactericidal and opsonic antibodies in mice[J]. Clin Vaccine Immunol, 2011, 18(11): 1817-22.
  • 3Unemo M, Dillon JA. Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their im- plications for improved knowledge of gonoeoccal epidemiology, treatment, and biology[J]. Clin Microbiol Rev, 2011, 24 (3): 447-58.
  • 4Christodoulides M. Neisseria proteomics for antigen discovery and vaccine development[J]. Expert Rev Proteomics, 2014, 11 (5) : 573-91.
  • 5Chen A, Seifert HS. Saturating mutagenesis of an essential gene: a majority of the Neisseria gonorrhoeae major outer membrane porin (PorB) ismutable[J]. J Baeteriol, 2014, 196(3): 540-7.
  • 6Karosiene E, Rasmussen M, Blicher T, et al. NetMHCIIpan-3. 0, a common pan-specific MHC class II prediction method inclu- ding all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ[J]. Immunogenetics, 2013, 65(10): 711-24.
  • 7Chen A, Seifert HS. Structure-function studies of the Neisseria gonorrhoeae major outer membrane porin [J]. Infect Immun, 2013, 81(12): 4383-91.
  • 8Jiang JH, Davis JK, Lithgow T SRA, et al. Targeting of Neis- serial PorB to the mitochondrial outer membrane: an insight onthe evolution of beta-barrel protein assembly machines[J]. Molmicrobiol, 2011, 82(4): 976-87.
  • 9Morgulis A, Coulouris G, Raytselis TL, et al. Database Inde- xing for Production MegaBLAST Searehes[J]. Bioinformatics, 2008, 24(16): 1757-64.
  • 10Roider J, Meissner T, Kraut F, et al. Comparison of experi- mental fine-mapping to in silico prediction results of HIV-1 epitopes reveals ongoing need for mapping experiments[J]. Im- munology, 2014, 143(2) : 193-201.

共引文献19

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部